Literature DB >> 17633659

[Head and neck reconstructive surgery with free flaps and quality of life: a prospective study].

A Bozec1, G Poissonnet, S Converset, L Lattes, E Chamorey, F Demard, O Dassonville.   

Abstract

OBJECTIVE: The aim of this prospective study is to evaluate functional results and quality of life after head and neck reconstructive surgery with free flaps.
MATERIAL AND METHODS: All patients who have beneficed of head and neck reconstructive procedures with free flaps during the year 2004 were included in this study. EORTC quality of life questionnaire (QLQ-C30/H&N35) was used before and 6 months after surgery. A head and neck functional evaluation was realized 6 months after surgery.
RESULTS: Thirty four patients were examinate 6 months after surgery. Global quality of life remained at its preoperative level (61.3% VS 62.8%). Physical, role and social functioning decreased significantly (p = 0.05), but emotional and cognitive functioning remained stable. Pain decreased considerably after treatment in the head and neck area (p = 0.001). Oral (eating: p = 0.05, speaking: p = 0.008) and sensorial functions (p = 0.001) decreased after treatment. All patients except one have recovered sufficient oral intakes, an intelligible speech and a good cosmetic result.
CONCLUSION: Functional and cosmetic results after head and neck reconstructive surgery are the key factors of quality of life. Free flaps are considered actually as an indispensable technique to achieve an optimal reconstruction.

Entities:  

Mesh:

Year:  2007        PMID: 17633659

Source DB:  PubMed          Journal:  Rev Laryngol Otol Rhinol (Bord)        ISSN: 0035-1334


  1 in total

1.  Impact of patient comorbidities on head and neck microvascular reconstruction. A report on 423 cases.

Authors:  Clair Vandersteen; Olivier Dassonville; Emmanuel Chamorey; Gilles Poissonnet; Eric Edi Martial Nao; Cédric Sandy Pierre; Axel Leyssale; Frédéric Peyrade; Marie Noelle Falewee; Anne Sudaka; Juliette Haudebourg; François Demard; José Santini; Alexandre Bozec
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-19       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.